Innovation & Excitement Rule at Groundbreaking Pharma Market Research Conference

The Pharma Market Research Conference (PMRC) just closed the book on another game-changing event, this time at a new venue located in Newark, New Jersey. This year’s groundbreaking agenda reflected the new space by bringing fresh perspectives and solutions to the critical issues facing the industry. The program (featuring 60+ sessions!) contributed to PMRC’s long-standing tradition of presenting the most relevant topics with the most qualified speakers.

The executive keynotes included talks from Adelene Perkins, Chair and Chief Executive Officer of Infinity Pharmaceuticals (“Daring to Believe in a Cure and Why the Belief is Justified”) and Analia de la Fuente, Vice President & Global Head of Patient Ecosystem Insights Practice, UCB (“Orchestrating Future-Looking Capability in Insight”).

An exciting addition to this year’s event—the “PMRC Award of the Year.” Each presenter was eligible to win this new award, and attendees voted to determine who would take home the prize. In the end, it was Anne Hale, U.S. BAI I&I Lead, Pfizer and Will Leopold, Account Director, Life Sciences, CMI, whose talk, “Why Should You Care about Prescribing Habits and Brand Consideration?” clinched the award.

The tradition of excellence continues for the best Pharma Market Research Conference. Interested in more PMRC? Up next is the Bay Area Pharma Market Research Conference, held June 12-13 at the Embassy Suites by Hilton San Francisco Airport.

Meanwhile, stay tuned for 2019 when PMRC celebrates 10 YEARS!

Visit: www.pharmamarketresearchconference.com.

Adelene Perkins, Chair and Chief Executive Officer of Infinity, kicks off the 2018 PMRC with her keynote, “Daring to Believe in a Cure and Why the Belief is Justified.”
Roger Green, President/CEO of RG+A, takes advantage of the networking opportunities in the PMRC Exhibition Hall.
The PMRC Exhibition Hall is a great place to connect and strengthen relationships.
It’s a full house as attendees gather to hear the latest in innovations and research from one of PMRC’s celebrated speakers.
Congratulations! Pfizer’s Anne Hale and CMI’s Will Leopold celebrate winning the PMRC Award of the Year.
Roundtable lead by Rich McCloud (Pfizer) on “Biosimilars: Considerations for Launch.”

Ads

You May Also Like

High Growth Anticipated for the Duchenne Muscular Dystrophy (DMD) Market

The Duchenne Muscular Dystrophy (DMD) treatment market is expected to change radically by 2019 ...

Movers & Shakers

Novartis and Bayer The Novartis Annual Meeting in February promises to be a major ...

Movers and Shakers December 2015

  J. Knipper Appoints New Chief Technology Officer Based on his many years of ...